Page last updated: 2024-12-10

picroside ii

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

picroside II: RN given for (1aS-(1aalpha,1bbeta,2beta,5abeta,6beta,6abeta))-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID146158804
MeSH IDM0374533

Synonyms (1)

Synonym
picroside ii

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" This method was applied to the pharmacokinetic study of picroside II in dogs."( Determination of picroside II in dog plasma by HPLC and its application in a pharmacokinetics study.
Xu, LZ; Yang, FC; Yang, SL, 2005
)
0.33
" With the aid of the efficient and reliable simultaneous LC-ESI-MS/MS assay this pharmacokinetic study provided insights into their therapeutic targets of these three iridoid glycosides as well as valuable experimental basis for an expansion of their clinical indications."( A pre-clinical pharmacokinetic study in rats of three naturally occurring iridoid glycosides, Picroside-I, II and III, using a validated simultaneous HPLC-MS/MS assay.
Liu, L; Liu, M; Ma, B; Qi, H; Wang, Y; Wu, Z; Xue, B; Yao, D; Ying, H; Zhang, Q; Zhu, J, 2015
)
0.42
" Therefore, this study was designed to check metabolic (in vitro and in vivo) profile along with pharmacokinetic profile of picroside I and II."( In vitro - In vivo metabolism and pharmacokinetics of picroside I and II using LC-ESI-MS method.
Anandjiwala, S; Nivsarkar, M; Padh, H; Upadhyay, D, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
"05) in oral bioavailability of picrosides I and II from different preparations."( Comparative pharmacokinetic profiles of picrosides I and II from kutkin, Picrorhiza kurroa extract and its formulation in rats.
Anandjiwala, S; Dash, RP; Nivsarkar, M; Upadhyay, D, 2013
)
0.39
" Previously, we have reported that oral bioavailability of picroside I and II is low."( In vitro - In vivo metabolism and pharmacokinetics of picroside I and II using LC-ESI-MS method.
Anandjiwala, S; Nivsarkar, M; Padh, H; Upadhyay, D, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" Picroside 2 and salvianic acid A sodium were respectively injected from tail vein at the dosage of 10 mg/kg for treatment."( Anti-inflammation effects of picroside 2 in cerebral ischemic injury rats.
Du, F; Guo, Y; Li, Q; Li, Z; Xu, X, 2010
)
0.36
"We analyzed the effective half-maximal concentration for protection from the dose-response curves and obtained the concentration of 50 µg/mL as EC(50)."( The protective effect of picroside II against hypoxia/reoxygenation injury in neonatal rat cardiomyocytes.
Hou, ZW; Li, Y; Meng, FJ; Yang, Y; Yu, B, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (71)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (14.08)29.6817
2010's50 (70.42)24.3611
2020's11 (15.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (98.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]